Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Lacrimo-auriculo-dento-digital (LADD) syndrome is an autosomal dominant congenital anomaly disorder characterized by aplasia or hypoplasia of lacrimal and salivary glands, cup-shaped ears, hearing loss, dental defects, and digital anomalies. Heterozygous loss-of-function variants in FGF10 disrupt terminal branching of glandular and pulmonary epithelia via the TBX4-FGF10-FGFR2 signaling axis.
Multiple distinct FGF10 pathogenic alleles have been identified across unrelated families. A nonsense variant c.190G>T (p.Gly64Ter) was reported in a LADD pedigree, and a 12 158 bp deletion removing two FGF10 exons segregated in seven affected individuals ([PMID:16630169]; [PMID:33967277]). Segregation in multi-generational cohorts supports an autosomal dominant haploinsufficiency mechanism.
Functional assays demonstrate that LADD-associated FGF10 mutants severely impair FGF10–FGFR2b binding and downstream ERK phosphorylation, consistent with in vitro studies of paracrine signaling loss ([PMID:17682060]). Mouse models harboring Fgf10 splice or missense mutations recapitulate gland hypoplasia and ocular surface defects, including Harderian gland atrophy and slit-eye phenotypes ([PMID:19407009]; [PMID:15972105]).
No conflicting evidence has emerged to dispute the FGF10–LADD association, although phenotypic expressivity varies, likely due to modifier loci. Additional splice-site and missense variants in aplasia of lacrimal and salivary glands (ALSG) further define a continuous FGF10-related clinical spectrum.
Integration of genetic and experimental data yields a Strong ClinGen‐level association. Inclusion of FGF10 in diagnostic gene panels for congenital lacrimal and salivary gland disorders enables targeted management and genetic counseling. Key take-home: FGF10 haploinsufficiency reliably underlies LADD syndrome and should be systematically tested in relevant clinical presentations.
Gene–Disease AssociationStrongMultiple unrelated probands (≥8) including a 12 kb deletion in seven individuals [PMID:33967277], segregation in multi-generational families [PMID:16630169], concordant functional data [PMID:17682060] Genetic EvidenceStrongIdentification of loss-of-function and missense variants in >10 affected individuals across several pedigrees with clear segregation, reaching the ClinGen genetic cap Functional EvidenceModerateIn vitro assays show impaired FGF10–FGFR2b signaling ([PMID:17682060]), and mouse models recapitulate glandular hypoplasia with rescue experiments confirming pathway specificity ([PMID:19407009]; [PMID:15972105]) |